Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Argenx Se (ARGX) EBT (2016 - 2026)

Argenx Se filings provide 11 years of EBT readings, the most recent being $438.0 million for Q1 2026.

  • On a quarterly basis, EBT rose 148.86% to $438.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 303.65% increase, with the full-year FY2025 number at $1.3 billion, up 1401.06% from a year prior.
  • EBT hit $438.0 million in Q1 2026 for Argenx Se, up from $412.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $438.0 million in Q1 2026 to a low of -$230.1 million in Q1 2022.
  • Median EBT over the past 5 years was $128.4 million (2022), compared with a mean of $109.2 million.
  • Biggest five-year swings in EBT: plummeted 686.6% in 2022 and later surged 3769.09% in 2025.
  • Argenx Se's EBT stood at $128.4 million in 2022, then surged by 39.4% to $178.9 million in 2023, then decreased by 20.56% to $142.1 million in 2024, then surged by 190.2% to $412.5 million in 2025, then increased by 6.19% to $438.0 million in 2026.
  • The last three reported values for EBT were $438.0 million (Q1 2026), $412.5 million (Q4 2025), and $388.9 million (Q3 2025) per Business Quant data.